Functional Analysis of Genetic Variation in Catechol-O-Methyltransferase (COMT): Effects on mRNA, Protein, and Enzyme Activity in Postmortem Human Brain
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Catechol-O-methyltransferase (COMT) is a key enzyme in the elimination of dopamine in the prefrontal cortex of the human brain. Genetic variation in the COMT gene (MIM 116790) has been associated with altered prefrontal cortex function and higher risk for schizophrenia, but the specific alleles and their functional implications have been controversial. We analyzed the effects of several single-nucleotide polymorphisms (SNPs) within COMT on mRNA expression levels (using reverse-transcriptase polymerase chain reaction analysis), protein levels (using Western blot analysis), and enzyme activity (using catechol methylation) in a large sample (n = 108) of postmortem human prefrontal cortex tissue, which predominantly expresses the -membrane-bound isoform. A common coding SNP, Val158Met (rs4680), significantly affected protein abundance and enzyme activity but not mRNA expression levels, suggesting that differences in protein integrity account for the difference in enzyme activity between alleles. A SNP in intron 1 (rs737865) and a SNP in the 3' flanking region (rs165599)--both of which have been reported to contribute to allelic expression differences and to be associated with schizophrenia as part of a haplotype with Val--had no effect on mRNA expression levels, protein immunoreactivity, or enzyme activity. In lymphocytes from 47 subjects, we confirmed a similar effect on enzyme activity in samples with the Val/Met genotype but no effect in samples with the intron 1 or 3' SNPs. Separate analyses revealed that the subject's sex, as well as the presence of a SNP in the P2 promoter region (rs2097603), had small effects on COMT enzyme activity. Using site-directed mutagenesis of mouse COMT cDNA, followed by in vitro translation, we found that the conversion of Leu at the homologous position into Met or Val progressively and significantly diminished enzyme activity. Thus, although we cannot exclude a more complex genetic basis for functional effects of COMT, Val is a predominant factor that determines higher COMT activity in the prefrontal cortex, which presumably leads to lower synaptic dopamine levels and relatively deleterious prefrontal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A polymorphism of COMT with decreased function (Chen et al., 2004), was associated with increased activation of the IFG during action cancelation (Congdon et al., 2009) and decreased interference inhibition (Solis-Ortiz et al., 2010), although conflicting results have also been reported (Kramer et al., 2007).”
From Response Inhibition and Interference Control in Obsessive–Compulsive Spectrum Disorders (2014) · cites this paper as Chen et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“The COMT enzyme plays a significant role in regulating frontal DA (Chen et al., 2004)”
From Impulsivity, frontal lobes and risk for addiction (2009) · cites this paper as Chen et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“The common rs4680 Val 158 Met single nucleotide polymorphism (SNP) leads to a reduction of COMT enzymatic activity in Met carriers (6-8).”
From Influence of the COMT genotype on working memory and brain activity changes during development (2011) · cites this paper as [6]
In the citing paper
“The COMT val allele is associated with high enzymatic activity and consequently low synaptic dopamine levels, whereas the COMT met allele results in approximately one third less enzyme activity and consequently high synaptic dopamine (Chen, Lipska et al. 2004).”
From Developmental imaging genetics: Linking dopamine function to adolescent behavior (2014) · cites this paper as Chen, Lipska et al. 2004
In the citing paper
“which are responsible for the bulk of dopamine degradation in the striatum and the prefrontal cortex respectively”
From DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls (2010) · cites this paper as Chen et al, 2004
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,381
Self-citationSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020
Self-citationEnzymatic O-methylation of epinephrine and other catechols
Axelrod, J., & Tomchick, R. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64731-3 · Cited by 1,283 · cited 1×
“Since its discovery in 1958 (Axelrod and Tomchick 1958), catechol-O-methyltransferase (COMT) has been an important enzyme in catecholamine biochemistry and pharmacology and, more recently, in genetic mechanisms of variation in catechol metabolism and its clinical implications.”
BackgroundLotta, T., Vidgren, J., Tilgmann, C., Ulmanen, I., Melen, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167
Psychopharmacology: The Fourth Generation of Progress
Green, A. I. (1996) · Psychiatric Services · doi:10.1176/ps.47.3.312 · Cited by 1,145
Mattay, V. S., Goldberg, T. E., Fera, F., Hariri, A. R., Tessitore, A., Egan, M. F., Kolachana, B., Callicott, J. H., & Weinberger, D. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931309100 · Cited by 893 · cited 1×
“Indeed, clinical studies of COMT have revealed that the Met allele, which encodes the enzyme with lower activity, is associated with better performance on tests of prefrontally mediated cognition (Egan et al. 2001; Goldberg et al. 2003; Mattay et al. 2003; Diamond et al. 2004; Nolan et al. 2004).”
BackgroundSelf-citationGogos, J. A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D., & Karayiorgou, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9991 · Cited by 864
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Badner, J. A., & Gershon, E. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001012 · Cited by 811
Prefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Self-citation
Cited by
Items 501–600 of 1,003
Hall, K. T., Nelson, C. P., Davis, R. B., Buring, J. E., Kirsch, I., Mittleman, M. A., Loscalzo, J., Samani, N. J., Ridker, P. M., Kaptchuk, T. J., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303845 · Cited by 42
Clelland, C. L. T., Drouet, V., Rilett, K. C., Smeed, J., Nadrich, R. H., Rajparia, A., Read, L. L., & Clelland, J. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.157 · Cited by 42
Sapkota, S., Bäckman, L., & Dixon, R. A. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.022 · Cited by 42
SELECTION OF POLYMORPHIC LOCI FOR ASSOCIATION ANALYSIS IN GENETIC-EPIDEMIOLOGICAL STUDIES
Ponomarenko, I., Ponomarenko, I. V., & of the Ministry of Health of the Russian Federation (2018) · Research Result Medicine and Pharmacy · doi:10.18413/2313-8955-2018-4-2-0-5 · Cited by 42
22q11.2 deletion syndrome and schizophrenia
Qin, X., Jiang, C., & Zhou, T. G. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmaa113 · Cited by 42
Evers, L. J. M., van Amelsvoort, T., Candel, M. J. J. M., Boer, H., Engelen, J. J. M., & Curfs, L. (2014) · Journal of Intellectual Disability Research · doi:10.1111/jir.12117 · Cited by 42
COMT genotype and cognitive function: An 8-year longitudinal study in white and black elders
Fiocco, A. J., Lindquist, K. J., Ferrell, R. E., Li, R., Simonsick, E. M., Nalls, M. A., Harris, T. B., & Yaffe, K. S. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d9edba · Cited by 42
Swift‐Scanlan, T., Smith, C. T., Bardowell, S. A., & Boettiger, C. A. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-5 · Cited by 42
Cannabis use, COMT, BDNF and age at first-episode psychosis
Mané, A., Bergé, D., Penzol, M. J., Parellada, M., Bioque, M., Lobo, A., González-Pinto, A. M., Corripio, I., Cabrera, B., Sánchez-Torres, A. M., et al. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.01.045 · Cited by 42
Genetic polymorphism of catechol-O-methyltransferase and cytochrome P450c17 in preeclampsia
Lim, J. H., Kim, S. Y., Kim, D.-J., Park, S. Y., Han, H. W., Han, J. Y., Lee, S. W., Yang, J. H., & Ryu, H. M. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833df033 · Cited by 41
Heitland, I., Kenemans, J. L., Oosting, R. S., Baas, J. M. P., & Böcker, K. B. E. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.013 · Cited by 41
Lovallo, W. R., Enoch, M.-A., Sorocco, K. H., Vincent, A. S., Acheson, A., Cohoon, A. J., Hodgkinson, C. A., & Goldman, D. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000481 · Cited by 39
Siomek, A., Długosz, A., & Czarnecki, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084262 · Cited by 41
COMT Val108/158Met Polymorphism and the Modulation of Task-Oriented Behavior in Children with ADHD
Sengupta, S. M., Grizenko, N., Schmitz, N., Schwartz, G. J., Bellingham, J., Polotskaia, A., Ter-Stepanian, M., Goto, Y., Grace, A. A., & Joober, R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.85 · Cited by 41
COMT genotype and its role on hippocampal–prefrontal regions in declarative memory
Krach, S., Jansen, A., Krug, A., Markov, V., Thimm, M., Sheldrick, A. J., Eggermann, T., Zerres, K., Stöcker, T., Shah, N. J., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.12.090 · Cited by 41
Yılmaz, Z., Kaplan, A. S., Zai, C. C. H., Levitan, R. D., & Kennedy, J. L. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.01.012 · Cited by 41
TheCOMTandDRD3genes interacted in bipolar I but not bipolar II disorder
Lee, S.-Y., Chen, S., Chen, S., Huang, S., Tzeng, N., Chang, Y., Wang, C., Lee, I. H., Yeh, T. L., Yang, Y. K., et al. (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2010.505298 · Cited by 41
Matsuzaka, C. T., Christofolini, D. M., Ota, V., Gadelha, A., Berberian, A. D. A., Noto, C. D. S., Mazzotti, D. R., Spíndola, L., Moretti, P. N. S., Smith, M. D. A. C., et al. (2017) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2016-1987 · Cited by 41
Emotional stability is associated with the MAOA promoter uVNTR polymorphism in women
Rodríguez‐Ramos, Á., Moriana, J. A., García‐Torres, F., & Ruiz‐Rubio, M. (2019) · Brain and Behavior · doi:10.1002/brb3.1376 · Cited by 41
Genetic variation in COMT activity impacts learning and dopamine release capacity in the striatum
Simpson, E. H., Morud, J., Winiger, V., Biezonski, D., Zhu, J. P., Bach, M. E., Malleret, G., Polan, H. J., Ng-Evans, S., Phillips, P. E. M., et al. (2014) · Learning & Memory · doi:10.1101/lm.032094.113 · Cited by 41
Comt1 genotype and expression predicts anxiety and nociceptive sensitivity in inbred strains of mice
Segall, S. K., Nackley, A. G., Diatchenko, L., Lariviere, W. R., Lu, X., Marron, J. S., Grabowski‐Boase, L., Walker, J. R., Slade, G., Gauthier, J., et al. (2010) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00633.x · Cited by 37
Kim, H. K., Blumberger, D. M., Downar, J. H., & Daskalakis, Z. J. (2020) · Clinical Neurophysiology · doi:10.1016/j.clinph.2020.11.025 · Cited by 40
Vetterlein, A., Monzel, M., & Reuter, M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105112 · Cited by 40
Habig, C., Geffers, R., & Distl, O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046787 · Cited by 40
Wang, Y., Hu, Y., Fang, Y., Zhang, K., Yang, H., Ma, J., Xu, Q., & Shen, Y. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.027 · Cited by 40
Imaging Genomics Applied to Anxiety, Stress Response, and Resiliency
Xu, K., Ernst, M., & Goldman, D. A. (2006) · Neuroinformatics · doi:10.1385/ni:4:1:51 · Cited by 40
Neurophysiological markers of novelty processing are modulated by COMT and DRD4 genotypes
Marco‐Pallarés, J., Nager, W., Krämer, U. M., Cunillera, T., Càmara, E., Cucurell, D., Schüle, R., Schöls, L. J., Rodríguez‐Fornells, A., & Münte, T. F. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.012 · Cited by 40
Espinoza, S., Managò, F., Leo, D., Sotnikova, T. D., & Gainetdinov, R. R. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800672436 · Cited by 40
Qian, Q.-J., Liu, J., Wang, Y.-F., Yang, L., Guan, L.-L., & Faraone, S. V. (2009) · Behavioral and Brain Functions · doi:10.1186/1744-9081-5-8 · Cited by 33
COMT and MTHFR polymorphisms interaction on cognition in schizophrenia: An exploratory study
Kontis, D., Theochari, E., Fryssira, H., Kleisas, S., Sofocleous, C., Andreopoulou, A., Kalogerakou, S., Gazi, A., Boniatsi, L., Chaidemenos, A., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.01.012 · Cited by 39
Effect of the COMT Val158Met genotype on lateral prefrontal activations in young children
Moriguchi, Y., & Shinohara, I. (2018) · Developmental Science · doi:10.1111/desc.12649 · Cited by 39
Ji, K., Liang, H., Ren, M., Ge, X., Liu, B., Xi, B., Pan, L., & Yu, H. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.08.006 · Cited by 39
COMT val158met influence on electroconvulsive therapy response in major depression
Domschke, K., Zavorotnyy, M., Diemer, J., Nitsche, S., Hohoff, C., Baune, B. T., Deckert, J., Arolt, V., & Zwanzger, P. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30949 · Cited by 39
The V108M mutation decreases the structural stability of catechol O-methyltransferase
Rutherford, K., Alphandéry, E., McMillan, A. W., Daggett, V., & Parson, W. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.04.006 · Cited by 39
Erjavec, G. N., Perković, M. N., Borovečki, F., Hajnšek, S., Mück‐Šeler, D., & Pivac, N. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.02.050 · Cited by 39
Thakur, G. A., Sengupta, S. M., Grizenko, N., Choudhry, Z., & Joober, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049616 · Cited by 33
Ittiwut, R., Listman, J. B., Ittiwut, C., Cubells, J. F., Weiss, R. D., Brady, K. T., Oslin, D. W., Farrer, L. A., Kranzler, H. R., & Gelernter, J. E. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31205 · Cited by 39
Adolescence is the starting point of sex-dichotomous COMT genetic effects
Sannino, S., Padula, M. C., Managò, F., Schaer, M., Schneider, M., Armando, M., Scariati, E., Béna, F., Mereu, M., Pontillo, M., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.109 · Cited by 39
Omidvar, M., Stolk, L., Uitterlinden, A. G., Hofman, A., van Duijn, C. M., & Tiemeier, H. W. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328317f3f8 · Cited by 39
Spatial DNA Melting Analysis for Genotyping and Variant Scanning
Crews, N. D., Wittwer, C. T., Montgomery, J., Pryor, R., & Gale, B. K. (2009) · Analytical Chemistry · doi:10.1021/ac801495w · Cited by 39
Aggression and polymorphisms in AR, DAT1, DRD2 and COMT genes in Datoga pastoralists of Tanzania
Butovskaya, M., Vasilyev, V. A., Lazebny, O. E., Suchodolskaya, E. M., Shibalev, D. V., Куликов, А. М., Карелин, Д. В., Burkova, V. N., Mabulla, A. Z. P., & Рысков, А. П. (2013) · Scientific Reports · doi:10.1038/srep03148 · Cited by 38
Mizuno, Y., Jung, M., Fujisawa, T. X., Takiguchi, S., Shimada, K., Saito, D. N., Kosaka, H., & Tomoda, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-04579-8 · Cited by 39
Kumar, P., & Rai, V. (2019) · Metabolic Brain Disease · doi:10.1007/s11011-019-00495-0 · Cited by 38
Jung, Y.-H., Kang, D.-H., Byun, M. S., Shim, G., Kwon, S. J., Jang, G.-E., Lee, U. S., An, S. C., Jang, J. H., & Kwon, J. S. (2012) · Stress · doi:10.3109/10253890.2011.592880 · Cited by 33
Robinson, R., Smith, S. M., Wolkenberg, S., Kandebo, M., Yao, L., Gibson, C. R., Harrison, S. T., Polsky-Fisher, S., Barrow, J., Manley, P., et al. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200109w · Cited by 34
Proline and COMT Status Affect Visual Connectivity in Children with 22q11.2 Deletion Syndrome
Magnée, M. J. C. M., Lamme, V. A. F., der Velden, M. G. M. D. S., Vorstman, J. A. S., & Kemner, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025882 · Cited by 38
Boot, E., Booij, J., Abeling, N. G. G. M., Meijer, J. H., Alves, F. D. S., Zinkstok, J., Baas, F., LINSZEN, D. H., & van Amelsvoort, T. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400644 · Cited by 38
Reward Sensitivity of ACC as an Intermediate Phenotype between DRD4-521T and Substance Misuse
Baker, T. E., Stockwell, T. R., Barnes, G. E., Haesevoets, R. J. C., & Holroyd, C. B. (2016) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00905 · Cited by 38
Yang, J., & Li, M. D. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.67 · Cited by 38
Klaus, K., Butler, K., Durrant, S. J., Ali, M., Inglehearn, C. F., Hodgson, T. L., Gutiérrez, H., & Pennington, K. (2017) · Brain and Behavior · doi:10.1002/brb3.695 · Cited by 38
Benedetti, F., Dallaspezia, S., Locatelli, C., Radaelli, D., Poletti, S., Lorenzi, C., Pirovano, A., Colombo, C., & Smeraldi, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.022 · Cited by 37
Bortsov, A. V., Diatchenko, L. B., & McLean, S. A. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8255-9 · Cited by 37
Neurobiological regulation of eating behavior: Evidence based on non-invasive brain stimulation
Ester-Nacke, T., & Kullmann, S. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09697-3 · Cited by 38
Voisey, J., Swagell, C. D., Hughes, I. P., Lawford, B. R., Young, R. M., & Morris, C. P. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-51 · Cited by 38
Genetic differences in emotionally enhanced memory
Todd, R. M., Palombo, D. J., Levine, B., & Anderson, A. K. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.11.010 · Cited by 37
Imaging Epigenetics in Alzheimer’s Disease
Lista, S., Garaci, F., Toschi, N., & Hampel, H. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990370 · Cited by 36
Schulz‐Heik, R. J., Schaer, M., Eliez, S., Hallmayer, J. F., Lin, X., Kaloupek, D. G., & Woodward, S. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.012 · Cited by 37
Shen, X., Wu, Y., Guan, T., Wang, X., Qian, M., Lin, M., Shen, Z., Sun, J., Zhong, H., Yang, J., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.008 · Cited by 37
Miller, R. J., Jackson, K. G., Dadd, T., Mayes, A. E., Brown, A. L., & Minihane, A. M. (2010) · British Journal Of Nutrition · doi:10.1017/s0007114510004836 · Cited by 37
Miller, R. J., Jackson, K. G., Dadd, T., Nicol, B., Dick, J. L., Mayes, A. E., Brown, A. L., & Minihane, A. M. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0189-0 · Cited by 37
Gene x environment interactions in conduct disorder: Implications for future treatments
Holz, N. E., Zohsel, K., Laucht, M., Banaschewski, T., Hohmann, S., & Brandeis, D. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.017 · Cited by 37
Satterfield, B. C., Hinson, J. M., Whitney, P., Schmidt, M. A., Wisor, J. P., & Van Dongen, H. P. A. (2018) · Cortex · doi:10.1016/j.cortex.2017.11.012 · Cited by 36
Shehzad, Z. E., DeYoung, C. G., Kang, Y., Grigorenko, E. L., & Gray, J. R. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.097 · Cited by 36
Impact of COMT genotype on cognition in schizophrenia spectrum patients and their relatives.
García, P., Espinoza, L. Y., Santos, P. M., Marín-Méndez, J. J., & Sánchez-Pedreño, F. O. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.043 · Cited by 32
Myrga, J. M., Failla, M. D., Ricker, J. H., Dixon, C. E., Conley, Y. P., Arenth, P. M., & Wagner, A. K. (2015) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000199 · Cited by 36
Effects of tolcapone and bromocriptine on cognitive stability and flexibility
Cameron, I. G. M., Wallace, D. L., Al-Zughoul, A. B., Kayser, A. S., & D’Esposito, M. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4845-4 · Cited by 36
COMT Val 158 Met and Cognitive and Functional Outcomes after Traumatic Brain Injury
Willmott, C., Withiel, T., Ponsford, J. L., & Burke, R. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3308 · Cited by 36
Laatikainen, L. M., Sharp, T., Bannerman, D., Harrison, P. J., & Tunbridge, E. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112454228 · Cited by 36
Hirvonen, M., Någren, K., Rinne, J. O., Pesonen, U., Vahlberg, T. J., Hagelberg, N. M., & Hietala, J. A. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0257-5 · Cited by 36
Coman, I. L., Gnirke, M. H., Middleton, F. A., Antshel, K. M., Fremont, W. P., Higgins, A. M., Shprintzen, R. J., & Kates, W. R. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.01.094 · Cited by 36
Xia, H., Wu, N., & Su, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049768 · Cited by 36
COMT Val 158 Met genotype influences neurodegeneration within dopamine-innervated brain structures
Gennatas, E. D., Cholfin, J. A., Zhou, J. H., Crawford, R. K., Sasaki, D. A., Karydas, A., Boxer, A. L., Bonasera, S. J., Rankin, K. P., Gorno‐Tempini, M. L., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182574fa1 · Cited by 36
Salatino‐Oliveira, A., Genro, J. P., Zeni, C., Polanczyk, G. V., Chazan, R., Guimarães, A. P., Callegari-Jacques, S. M., Rohde, L. A., & Hutz, M. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.025 · Cited by 36
Pharmacogenetics of Chronic Pain and Its Treatment
Světlík, S., Hronová, K., Bakhouche, H., Matoušková, O., & Slanař, O. (2013) · Mediators of Inflammation · doi:10.1155/2013/864319 · Cited by 36
Landi, N., Frost, S. J., Mencl, W. E., Preston, J. L., Jacobsen, L. K., Lee, M., Yrigollen, C. M., Pugh, K. R., & Grigorenko, E. L. (2012) · Developmental Science · doi:10.1111/j.1467-7687.2012.01180.x · Cited by 36
Nieman, D. H., Dragt, S., van Duin, E. D. A., Denneman, N., Overbeek, J. M., de Haan, L., Rietdijk, J., Ising, H. K., Klaassen, R. M. C., van Amelsvoort, T., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.03.015 · Cited by 36
Comasco, E., Gulinello, M. E., Hellgren, C., Skalkidou, A., Sylvén, S. M., & Poromaa, I. S. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.01.002 · Cited by 36
Vai, B., Riberto, M., Poletti, S., Bollettini, I., Lorenzi, C., Colombo, C., & Benedetti, F. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.10.002 · Cited by 36
Papaleo, F., Sannino, S., Piras, F., & Spalletta, G. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.005 · Cited by 35
A COMT gene haplotype associated with methamphetamine abuse
Jugurnauth, S. K., Chen, C., Barnes, M. R., Li, T., Lin, S., Liu, H., Collier, D. A., & Breen, G. D. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834a53f9 · Cited by 35
Nilsson, S. R. O., Fejgin, K., Gastambide, F., Vogt, M. A., Kent, B. A., Nielsen, V., Nielsen, J., Gass, P., Robbins, T. W., Saksida, L. M., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw229 · Cited by 35
Hall, K. T., Buring, J. E., Mukamal, K. J., Moorthy, M. V., Wayne, P. M., Kaptchuk, T. J., Battinelli, E. M., Ridker, P. M., Sesso, H. D., Weinstein, S. J., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy204 · Cited by 35
Zhao, L., Yu, C., Lv, J., Cui, Y., Wang, Y., Hou, C., Yu, J., Guo, B., Liu, H., & Li, L. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111826 · Cited by 35
Cortical dopamine reduces the impact of motivational biases governing automated behaviour
Scholz, V., Hook, R. W., Kandroodi, M. R., Algermissen, J., Ioannidis, K., Christmas, D. M. B., Valle, S., Robbins, T. W., Grant, J. E., Chamberlain, S. R., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01291-8 · Cited by 36
Anorexia nervosa and the Val158Met polymorphism of the COMT gene: meta-analysis and new data
Brandys, M. K., Landt, M., Elburg, A. A. V., Ophoff, R. A., Verduijn, W., Meulenbelt, I., Middeldorp, C. M., Boomsma, D. I., van Furth, E. F., Slagboom, P. E., et al. (2012) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328351859e · Cited by 35
COMT Val108/158Met Gene Variant, Birth Weight, and Conduct Disorder in Children With ADHD
Sengupta, S. M., Grizenko, N., Schmitz, N., Schwartz, G. J., Amor, L. B., Bellingham, J., de Guzman, R., Polotskaia, A., Ter-Stepanian, M., THAKUR, G., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000251212.44491.46 · Cited by 35
Cerasa, A., Cherubini, A., Quattrone, A., Gioia, M. C., Tarantino, P., Annesi, G., Assogna, F., Caltagirone, C., & Spalletta, G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.040 · Cited by 34
Yu, H., Zhang, W., Xu, X. R., & Chen, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-35743-y · Cited by 34
Jiang, W., Shang, S., & Su, Y. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01569 · Cited by 34
Lanni, C., Garbin, G., Lisa, A., Biundo, F., Ranzenigo, A., Sinforiani, E., Cuzzoni, G., Govoni, S. M., Ranzani, G. N., & Racchi, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120358 · Cited by 34
Burghardt, K. J., & Ellingrod, V. L. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0017-8 · Cited by 34
Molecular Mechanisms in 22q11 Deletion Syndrome
Williams, N. M. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr095 · Cited by 34
Zhang, D., Rajaratnam, V. S., Al-Hendy, O., Halder, S. K., & Al-Hendy, A. A. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000363410 · Cited by 34
Stoddard, J., Beckett, L. A., & Simon, T. J. (2010) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9070-3 · Cited by 35
Effect of functional catechol-O-methyltransferase Val158Met polymorphism on physical aggression
Kulikova, M. A., Maluchenko, N. V., Timofeeva, M. A., Shlepzova, V. A., Schegolkova, J. V., Sysoeva, O., Ivanitsky, A. M., & Tonevitsky, A. (2008) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-008-0006-9 · Cited by 34
Kok, R., Bakermans‐Kranenburg, M. J., van IJzendoorn, M. H., Velders, F. P., Linting, M., Jaddoe, V. W. V., Hofman, A., Verhulst, F. C., & Tiemeier, H. W. (2012) · Developmental Psychobiology · doi:10.1002/dev.21049 · Cited by 34
Hao, H., Shao, M., An, J., Chen, C., Feng, X., Xie, S., Gu, Z., & Chan, P. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.06.021 · Cited by 34
The “highs and lows” of the human brain on dopaminergics: Evidence from neuropharmacology
Martins, D., Mehta, M. A., & Prata, D. P. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.06.003 · Cited by 35
Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease
Bäckström, D. C., Domellöf, M., Granåsen, G., Linder, J., Mayans, S., Elgh, E., Zetterberg, H., Blennow, K., & Forsgren, L. (2017) · Acta Neurologica Scandinavica · doi:10.1111/ane.12812 · Cited by 34
Gurvich, C., & Rossell, S. L. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.11.045 · Cited by 33
Metadata
- Authors
- Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., Egan, M. F., Kleinman, J. E., & Weinberger, D. R.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weinberger, Daniel R.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-11
- Volume
- 75
- Issue
- 5
- Pages
- 807-821
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1182110
- OpenAlex
- W2054856852
- Cited by
- 1,675
- References
- 46
- Citations by year
- 2026: 21 · 2025: 39 · 2024: 47 · 2023: 41 · 2022: 68 · 2021: 76 · 2020: 72 · 2019: 102 · 2018: 73 · 2017: 94 · 2016: 110 · 2015: 110 · 2014: 118 · 2013: 109 · 2012: 103
- FWCI
- 17.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3182 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- catechol-O-methyltransferase, COMT Val158Met polymorphism, single nucleotide polymorphisms, prefrontal cortex, dopamine metabolism, schizophrenia, mRNA expression, protein abundance, postmortem brain, lymphocytes
- MeSH terms
- Analysis of Variance, Animals, Catechol O-Methyltransferase, Genotype, Humans, Lymphocytes, Methylation, Proteins, RNA, Messenger, Sex Factors, Genetic Variation, Blotting, Western, Gene Expression Regulation, Enzymologic, Mutagenesis, Site-Directed, Prefrontal Cortex, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.